findmyKOL
Clinical trialNCT01253473CompletedPhase 4Interventional

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)

SponsorNational Jewish HealthEnrollment46Pulmonary Disease, Chronic Obstructive
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main objective of the study is to see if using anti-inflammatory to patients with airway disease chronic obstructive pulmonary disease (COPD) phenotype will be more effective than using these treatments in patients with loss of lung tissue. Symbicort plus ipratropium/albuterol will be used for 12 weeks in an open-label study in subjects with airway predominant COPD.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Birmingham Medical Center

    Birmingham, Alabama, United States

  • Harbor Ucla Medical Center

    Torrance, California, United States

  • National Jewish Health

    Denver, Colorado, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • Reliant Medical Group

    Worcester, Massachusetts, United States

  • Temple University Medical Center

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BudesonideIpratropiumBudesonide / formoterol
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2012
Primary completion
30 Sept 2015
Completion
31 Jan 2016
Last update posted
19 Jan 2021
Registered enrollment
46
Registry id
NCT01253473
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.